← Back to Search

Ice Therapy for Injection Site Pain

N/A

Recruiting

Led By Olufemi Adams, MD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

All patients aged 18 or older evaluated by a single retina specialist at the University of Minnesota Department of Ophthalmology with a clinical indication necessitating an anti-VEGF intravitreal injection

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this will be assessed at 24-hours after the conclusion of the intravitreal injection

Awards & highlights

Study Summary

This trial looks at whether ice-therapy can help reduce pain for patients during intravitreal anti-VEGF injections.

Who is the study for?

This trial is for adults 18 or older who need an anti-VEGF intravitreal injection for eye conditions, as determined by a retina specialist at the University of Minnesota Department of Ophthalmology. There are no specific exclusion criteria listed.Check my eligibility

What is being tested?

The study is testing if applying ice on the skin (topical ice-therapy) before getting an eye injection can reduce pain compared to not using any ice. Patients' pain experiences with and without ice will be compared.See study design

What are the potential side effects?

Since this trial involves topical ice application, potential side effects may include discomfort from the cold, temporary numbness, or mild skin irritation at the site of application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older and need an eye injection for my condition, as advised by a retina specialist.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this will be assessed at 24-hours after the conclusion of the intravitreal injection

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this will be assessed at 24-hours after the conclusion of the intravitreal injection

This trial's timeline: 3 weeks for screening, Varies for treatment, and this will be assessed at 24-hours after the conclusion of the intravitreal injection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Burning assessed by the visual analog scale

Discomfort assessed by the visual analog scale

Itching assessed by the visual analog scale

+2 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Ice-therapyActive Control1 Intervention

Ice therapy will be provided prior to the provision of the intravitreal injection

Group II: No Ice-therapyPlacebo Group1 Intervention

No ice therapy will be provided prior to the provision of the intravitreal injection

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,379 Previous Clinical Trials

1,588,242 Total Patients Enrolled

1 Trials studying Hypothermia

120 Patients Enrolled for Hypothermia

Olufemi Adams, MDPrincipal InvestigatorUniversity of Minnesota

Media Library

Ice-therapy Clinical Trial Eligibility Overview. Trial Name: NCT05269823 — N/A

Hypothermia Research Study Groups: Ice-therapy, No Ice-therapy

Hypothermia Clinical Trial 2023: Ice-therapy Highlights & Side Effects. Trial Name: NCT05269823 — N/A

Ice-therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05269823 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings available for individuals to become a participant in this clinical trial?

"Affirmative. The available information on clinicaltrials.gov states that this medical study is actively enrolling patients since its inception date of April 1st 2022, and the most recent edits were done on July 12th 2022. This research requires a total of 250 individuals to be recruited between two locations."

Answered by AI

To what extent is this experiment being participated in by individuals?

"Affirmative. Clinicaltrials.gov serves as a repository of this trial's information and it indicates that recruitment began on April 1st 2022, with the most recent update occurring on July 12th 2022. To satisfy the study requirements, 250 participants must be sourced from two distinct locations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Topical Ice-therapy for Intravitreal Injections

Olufemi E. Adams 2022. "Topical Ice-therapy for Intravitreal Injections". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05269823.